{"id":1092,"date":"2025-05-28T15:28:14","date_gmt":"2025-05-28T13:28:14","guid":{"rendered":"https:\/\/aplusa.local\/?post_type=expertise&#038;p=1092"},"modified":"2026-02-16T17:59:12","modified_gmt":"2026-02-16T16:59:12","slug":"hematology","status":"publish","type":"expertise","link":"https:\/\/www.aplusaresearch.com\/fr\/expertise\/hematology\/","title":{"rendered":"H\u00e9matologie"},"content":{"rendered":"<p>L&#039;h\u00e9matologie \u00e9volue rapidement, les th\u00e9rapies innovantes transformant la prise en charge des maladies h\u00e9matologiques, qu&#039;elles soient malignes ou non. Chez {acf_brand_name}, nous avons acquis une expertise pointue dans ce domaine gr\u00e2ce \u00e0 des d\u00e9cennies d&#039;\u00e9tudes de march\u00e9 sp\u00e9cialis\u00e9es et de collecte de donn\u00e9es au niveau du patient. Nos \u00e9tudes de march\u00e9 (tracker), nos analyses de dossiers patients et nos m\u00e9thodologies avanc\u00e9es \u00e9clairent la prise de d\u00e9cision des m\u00e9decins, la s\u00e9quence des traitements et leur adoption sur le march\u00e9, pour des pathologies allant des lymphomes aux troubles de la coagulation.<\/p>\n\n\n\n<p>Qu\u2019il s\u2019agisse de soutenir une strat\u00e9gie en amont, de pr\u00e9parer un lancement ou de suivre la performance d\u2019un produit en march\u00e9, nous aidons nos clients \u00e0 d\u00e9passer la complexit\u00e9 pour anticiper les tendances et identifier les opportunit\u00e9s.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Domaines d\u2019expertise cl\u00e9s<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>My\u00e9lome multiple (MM)<\/li>\n\n\n\n<li>Leuc\u00e9mie (CLL\/AML)<\/li>\n\n\n\n<li>Lymphome (DLBCL\/MCL\/FL\/MZL\/HL\/ALCL)<\/li>\n\n\n\n<li>My\u00e9lofibrose (MF)<\/li>\n\n\n\n<li>Syndrome my\u00e9lodysplasique (SMD)<\/li>\n\n\n\n<li>H\u00e9moglobinurie paroxystique nocturne (HPN)<\/li>\n\n\n\n<li>B\u00eata-thalass\u00e9mie<\/li>\n\n\n\n<li>H\u00e9mophilie A et B<\/li>\n\n\n\n<li>PTI (Purpura Thrombocytop\u00e9nique Immunitaire)<\/li>\n<\/ul>","protected":false},"featured_media":4023,"template":"","meta":{"_acf_changed":true,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"%%sitetitle%% provides hematology research insights to help pharma teams understand treatment landscapes, stakeholder needs, and market dynamics.","_seopress_robots_index":"","_seopress_analysis_target_kw":"","content-type":""},"class_list":["post-1092","expertise","type-expertise","status-publish","has-post-thumbnail"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/expertise\/1092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/expertise"}],"about":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/types\/expertise"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media\/4023"}],"wp:attachment":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media?parent=1092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}